Huidan Yu

Dr. Huidan Yu


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2022 in Complementary Therapies in Clinical Practice
Verified
Journal Article
Closed access
LTLanhui Tan
Lanhui Tan
PFPei Fang
Pei Fang
JCJiaxin Cui
Jiaxin Cui
HYHuidan Yu
Huidan Yu
LYLiping Yu
Liping Yu

1 August 2018 in Patient Preference and Adherence
Verified
Journal Article
Open access
PDF file
ZCZi Chen
Zi Chen
JGJing Geng
Jing Geng
MWMian Wang
Mian Wang
LHLiu Hu
Liu Hu
GGGabriela Lima de Melo Ghisi
Gabriela Lima de Melo Ghisi
HYHuidan Yu
Huidan Yu
Objectives: It is necessary to assess disease-related knowledge in patients with coronary artery disease (CAD) for tailored patient education; however there is a lack of a well-validated measurement in China. The objective of this study was to translate and validate a Chinese version of the Coronary Artery Disease Education Questionnaire-II (CADEQ-II). Methods: The Chinese version of CADEQ-II was translated and culturally adapted. Then, it was tested for psychometric properties through a convenient sampling. Content validity was examined based on a panel of five experts. The item difficulty index and item discrimination index were calculated to assess the item difficulty and item discrimination. Internal consistency reliability was measured with the Cronbach’s alpha coefficient. Criterion-related validity was established through comparing scores in patients with different education levels. Construct validity was assessed through confirmatory factor analysis (CFA). Results: The Chinese version of the CADEQ-II was finalized after deleting three items and modifying two items from the original version. Three hundred and sixteen participants completed the whole questionnaire. Content validity index of the whole questionnaire was 0.87. The Cronbach’s alpha coefficient of the overall questionnaire was 0.907. The significant difference of the knowledge scores among patients with different education levels supported criterion-related validity. CFA confirmed the proposed four-factorial structure of the questionnaire. Conclusion: The Chinese version of CADEQ-II had an acceptable reliability and validity among Chinese patients with CAD. It could be used to develop individualized health education for Chinese patients with CAD. Also, it could serve as a suitable outcome measurement to evaluate the effectiveness of education interventions related to CAD.

4 July 2022 in Contemporary Nurse
Verified
Journal Article
Closed access
BXBing Xue
Bing Xue
HYHuidan Yu
Huidan Yu
XLXianwu Luo
Xianwu Luo
Enhanced recovery after surgery (ERAS) protocols are well established. Evidence describing nurses’ knowledge of ERAS is limited.To assess surgical nurses’ knowledge of ERAS and identify factors tha...

1 February 2022 in BMJ Open
Verified
Journal Article
Open access
PDF file
ZAZifen An
Zifen An
XMXianmei Meng
Xianmei Meng
PFPei Fang
Pei Fang
HYHuidan Yu
Huidan Yu
LYLiping Yu
Liping Yu
Introduction The number of patients with advanced cancer is rapidly increasing, and the disease burden among those with low socioeconomic status (SES) has accordingly become a global concern. Low SES can adversely impact patients with advanced cancer. The purpose of this systematic review is to shed light on the life experiences of patients with advanced cancer with low SES to help provide targeted and effective strategies to improve their quality of life. Methods and analysis We will include the following English databases: Cochrane Library, Cumulative Index to Nursing and Allied Health Literature, PubMed, MEDLINE, Embase, Web of Science, Joanna Briggs Institute (JBI) Database of Systematic Reviews, PsycINFO and OpenGrey, and the following Chinese databases: China National Knowledge Infrastructure, VIP Database for Chinese Technical Periodicals and Wanfang Data Knowledge Service Platform. A comprehensive search of qualitative studies on the experiences of patients with advanced cancer with low SES will be conducted from the above databases, with no age limit. Quality assessments of the studies will be independently performed by two reviewers using the JBI Critical Assessment Checklist, and any disagreements will be resolved through a discussion with a third reviewer. Relevant data will be extracted using the JBI standardised data extraction tools. The JBI meta-aggregation tool will be used to compare, analyse and summarise the original results. The reliability and credibility of the overall quality of the studies included will be evaluated using the JBI ConQual approach. Ethics and dissemination This study is based on existing public literature and therefore does not require a formal ethics review. The results of the study may be presented in peer-reviewed international journals and presented at scientific conferences. PROSPERO registration number CRD42021250423.